The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice
The Kaohsiung Journal of Medical Sciences · 20.08.2026
DOI: 10.1002/kjm2.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 20.08.2026. Verfasst von Yu-Lun Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
For cervical cancer, the choice between definitive radiotherapy (RT) and surgery has long been a topic of debate. Clinical factors, including histology and tumor burden, have been examined in prior studies. Given recent advances in RT and the incorporation of concurrent chemotherapy, our study seeks to assess the optimal treatment modality for cervical cancer in current clinical practice. The cancer registry database of a medical center was screened for cervical cancer patients. Patients receiving curative intent RT or surgery were included. Clinicopathological factors and treatment outcomes were retrospectively collected. The disease‐free survival (DFS) and overall survival (OS) were analyzed using Cox regression and Kaplan–Meier analyses. From 2007 to 2021, 369 squamous cell carcinoma (SCC) and 108 adenocarcinoma (AC) cases were enrolled. AC had an increasing proportion over time and was associated with worse survival. Comparing RT to surgery, RT was associated with inferior survival in both early‐stage AC (DFS, HR: 8.29, p < 0.001, 95% CI: 3.21–21.42) and SCC group (DFS, HR: 4.01, p < 0.001, 95% CI: 1.99–8.08). The difference was more robust in those with tumors smaller than 4 cm. For advanced‐stage disease, the inferiority of RT was observed in the SCC (DFS, HR: 1.85, p = 0.020, 95% CI: 1.10–3.11), but not AC group. There was no statistically significant intergroup difference observed between the AC and SCC groups regarding DFS of RT versus surgery. In our analysis, AC was an independent poor prognostic factor. Despite the addition of concurrent chemotherapy and advanced RT techniques, surgery‐based treatment was still associated with superior survival for early‐stage cervical cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Business Management, National Sun Yat-Sen University, Kaohsiung, Taiwan.
- Department of Administration, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Yu-Lun Wu, Chen-Wei Ho, Wen-Shiung Liou, Chun-Hao Yin, Jin-Shuen Chen, Yao-Shen Chen, Yu-Wei Lin, Ju-Chun Chien
Zitieren
APA
Wu, Y. L., Ho, C. W., Liou, W. S., Yin, C. H., Chen, J. S., Chen, Y. S., Lin, Y. W., & Chien, J. C. (2026). The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70272
Vancouver
Wu YL, Ho CW, Liou WS, Yin CH, Chen JS, Chen YS, et al. The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70272
BibTeX
@article{Wu2026,
author = {Wu, Yu-Lun and Ho, Chen-Wei and Liou, Wen-Shiung and Yin, Chun-Hao and Chen, Jin-Shuen and Chen, Yao-Shen and Lin, Yu-Wei and Chien, Ju-Chun},
title = {The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2026},
doi = {10.1002/kjm2.70272}
}
EUVIMED